Earnings Preview — 5177 total
Progressive Corporation heads into its June 17 earnings report with options sentiment still tilted bullish — though less aggressively so than a week ago — while the broader analyst debate over loss ratios and growth…
MetLife reports second-quarter results on June 16 against a backdrop of unusual momentum: the stock has climbed 13% over the past month to $88.84, and the Street has spent the last several weeks upgrading its view of…
Dr. Reddy's Laboratories arrives at its June 16 earnings release with the defining feature of this preview cycle now more pronounced than at any prior print: the short position has broken out to a new high, even as…
Datadog heads into its June 15 earnings report with short sellers reducing exposure, analysts raising targets in a cluster, and the stock recovering ground after last week's sharp drop — a setup that shifts attention…
Anterix reported last night and the market's verdict was immediate: a 26% single-day surge to $81.44, leaving the bears — and the analyst who downgraded the stock just eight days ago — firmly wrong-footed. The…
Seneca Foods Corporation reports quarterly results on June 12 against a backdrop of rising short interest and a stock that has quietly outperformed — a tension the print will need to resolve. Short positions have…
Lennar reports Q2 results today with a notable split between the bearish thesis built into positioning and a stock that just staged its sharpest single-day rally in months. Short interest has continued to build. The SI…
NAVN arrives at its June 12 earnings release with one defining piece of context hanging over the print: the last time it reported, the stock jumped 54% in a single day. That March 25 reaction reshapes how every other…
CBRS reports after the close Thursday with the stock up 10% on the week and the lending market at its tightest reading since listing. The borrow story has moved materially since the prior article. Availability has…
Opendoor Technologies reports Q1 results today with short sellers at their most aggressive in at least a month — yet the borrow market shows no sign of stress. Short interest has climbed to 18.3% of the free float, the…
NTRA reports today against a backdrop where its own chief executive has been a notable seller — and that insider activity is the most striking signal heading into the release. CEO Steven Chapman sold roughly $4.8…
Anterix heads into its June 11 earnings print with options positioning unusually tilted toward calls — a notable contrast to the cautious analyst backdrop established in the days prior. The options market is sending…
Armstrong World Industries reports Q2 results today against a backdrop of notable peer divergence and quietly rising short interest. The most striking feature of the setup is how sharply AWI has lagged its building…
Honeywell International arrives at today's earnings event carrying the most visible bruises of any print in the recent cycle — down 4.6% on Wednesday alone and 7.8% on the week to $205.88, extending a sell-off that…
Pershing Square Inc. arrives at its June 15 earnings date in a materially weaker position than it held just a week ago — the stock has shed 22% over the past month and 8% in the last five days alone, reopening the…
HNGE reports its first full quarterly earnings as a public company today with a clear tension: a stock up 12% over the past month, analysts broadly bullish, and yet shorts and insiders both adding to the…
VELO reports after the close today carrying one of the more charged short-interest setups in its peer group — 16.4% of the free float is sold short, and the borrow market has tightened meaningfully over the past two…
Hims & Hers Health enters its June 11 print with a positioning picture that has barely shifted since last week — short sellers remain deeply entrenched, options traders have pulled back from their most aggressive call…
Driven Brands Holdings reports tomorrow with the most important data story of the past month still in motion: short sellers have continued unwinding positions that were far heavier just six weeks ago. The short cover…
Summit Therapeutics heads into its June 10 earnings report with its own executives making a conspicuous case for the stock just days before the release. On June 4, CEO Maky Zanganeh purchased 100,000 shares at $14.60 —…
